Onyx Pharmaceuticals Announces N. Anthony Coles, M.D. Elected Chairman of Its Board of Directors
December 17 2012 - 8:00AM
Marketwired
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that its
Board of Directors has elected N. Anthony Coles, M.D., Chairman of
the Board. Dr. Coles is currently President, Chief Executive
Officer and a member of Onyx's Board. Paul Goddard, Ph.D., will
continue to serve as Lead Independent Director of the Onyx Board.
"On behalf of the Board of Directors, I would like to
congratulate Tony on this well-deserved appointment," said Dr.
Goddard. "Through his steadfast, focused leadership, Onyx has grown
exponentially, transforming from a company with one therapy to a
diversified biopharmaceutical leader with three approved treatments
to address some of the most difficult-to-treat cancers."
"Paul's leadership has been instrumental in our ability to
realize Onyx's growth and transformation," said Dr. Coles. "I look
forward to continuing our successful partnership as Onyx moves into
this next stage as a global, multi-product company."
About Onyx Pharmaceuticals, Inc. Based in
South San Francisco, California, Onyx Pharmaceuticals, Inc. is a
global biopharmaceutical company engaged in the development and
commercialization of innovative therapies for improving the lives
of people with cancer. The company is focused on developing novel
medicines that target key molecular pathways. For more information
about Onyx, visit the company's website at www.onyx.com.
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024